49
Participants
Start Date
January 15, 2018
Primary Completion Date
March 23, 2021
Study Completion Date
April 30, 2021
Cellavita HD lower dose
The participants will receive a total of 9 intravenous administrations of 1x10\^6 cells/weight range divided into three administrations per cycle. Each administration will occur every 30 days and cycles every 120 days (total of 3 cycles).
Cellavita HD higher dose
The participants will receive a total of 9 intravenous administrations of 2x10\^6 cells/weight range divided into three administrations per cycle. Each administration will occur every 30 days and cycles every 120 days (total of 3 cycles).
Placebo
The participants will receive a total of 9 intravenous administrations of placebo divided into three administrations per cycle. Each administration will occur every 30 days and cycles every 120 days (total of 3 cycles).
Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda., Valinhos
Cellavita Pesquisa Científica Ltda
OTHER
Azidus Brasil
INDUSTRY